G3139, a BCL-2 antisense oligo-nucleotide, in AML

Ann Hematol. 2004:83 Suppl 1:S93-4. doi: 10.1007/s00277-004-0850-2.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Clinical Trial, Phase II
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / genetics
  • Oligonucleotides, Antisense / adverse effects
  • Oligonucleotides, Antisense / pharmacokinetics
  • Oligonucleotides, Antisense / therapeutic use
  • RNA, Messenger / drug effects
  • RNA, Messenger / genetics
  • Thionucleotides / adverse effects*
  • Thionucleotides / pharmacokinetics
  • Thionucleotides / therapeutic use*

Substances

  • Oligonucleotides, Antisense
  • RNA, Messenger
  • Thionucleotides
  • oblimersen